• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CHAIRMAN & CEO Friedman Gary G bought $9,999,978 worth of shares (46,274 units at $216.10), increasing direct ownership by 1% to 3,351,337 units (SEC Form 4)

    6/27/24 7:47:18 PM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary
    Get the next $RH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    FRIEDMAN GARY G

    (Last) (First) (Middle)
    C/O RH
    15 KOCH ROAD, SUITE K

    (Street)
    CORTE MADERA CA 94925

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    RH [ RH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    X Officer (give title below) Other (specify below)
    CHAIRMAN & CEO
    3. Date of Earliest Transaction (Month/Day/Year)
    06/25/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/25/2024 P 6,955 A $213.6743(1) 3,312,018 D
    Common Stock 06/25/2024 P 19,161 A $215.0784(2) 3,331,179 D
    Common Stock 06/25/2024 P 8,084 A $215.9598(3) 3,339,263 D
    Common Stock 06/26/2024 P 400 A $214.4562(4) 3,339,663 D
    Common Stock 06/26/2024 P 9,575 A $219.2883(5) 3,349,238 D
    Common Stock 06/26/2024 P 2,099 A $219.8517(6) 3,351,337 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This transaction was executed in multiple trades ranging from $213.30 to $214.29. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    2. This transaction was executed in multiple trades ranging from $214.38 to $215.37. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    3. This transaction was executed in multiple trades ranging from $215.38 to $216.33. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    4. This transaction was executed in multiple trades ranging from $214.27 to $214.56. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    5. This transaction was executed in multiple trades ranging from $218.76 to $219.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    6. This transaction was executed in multiple trades ranging from $219.77 to $219.99. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
    /s/ Edward T. Lee, Attorney-in-Fact 06/27/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RH

    DatePrice TargetRatingAnalyst
    4/3/2025$410.00 → $130.00Buy → Underperform
    BofA Securities
    4/3/2025$200.00Buy → Neutral
    Citigroup
    4/3/2025$420.00 → $280.00Outperform
    Telsey Advisory Group
    3/24/2025$500.00 → $420.00Outperform
    Telsey Advisory Group
    1/30/2025$261.00 → $374.00Sell → Neutral
    Goldman
    1/13/2025$435.00 → $530.00Equal-Weight → Overweight
    Morgan Stanley
    1/8/2025$383.00 → $515.00Equal Weight → Overweight
    Barclays
    12/19/2024$485.00 → $500.00Market Perform → Outperform
    Telsey Advisory Group
    More analyst ratings

    $RH
    Financials

    Live finance-specific insights

    See more
    • RH Reports Fourth Quarter and Fiscal 2024 Results

      RH (NYSE:RH) has released its financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.715.9871 or 646.307.1963 for international callers (conference ID: 8284432). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury

      4/2/25 4:05:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH to Report Fourth Quarter and Fiscal Year 2024 Financial Results on April 2, 2025

      RH (NYSE:RH) today announced that it will report financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, on Wednesday, April 2, 2025 after market close. RH's fourth quarter and fiscal year 2024 financial results press release will include a shareholder letter from Chairman and Chief Executive Officer, Gary Friedman, highlighting the Company's continued evolution and recent performance. The shareholder letter and financial results will be posted to the Company's investor relations website at ir.rh.com. RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) on April 2, 2025. The live conference call may be

      3/24/25 6:45:00 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH Reports Third Quarter Fiscal 2024 Results

      RH (NYSE:RH) has released its financial results for the third quarter ended November 2, 2024, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.715.9871 or 646.307.1963 for international callers (conference ID: 3000234). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury lifestyle market. T

      12/12/24 4:05:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by CHIEF ACCOUNTING OFFICER Hargarten Christina

      4 - RH (0001528849) (Issuer)

      4/14/25 9:30:09 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form 4 filed by Officer Chaya Eri

      4 - RH (0001528849) (Issuer)

      4/14/25 9:30:07 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form 4 filed by Officer Duban Stefan

      4 - RH (0001528849) (Issuer)

      4/14/25 9:30:10 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more

    $RH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

      Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

      1/18/21 5:24:40 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

      Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

      1/18/21 5:24:40 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

      Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

      1/15/21 11:16:15 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • CHAIRMAN & CEO Friedman Gary G bought $9,999,978 worth of shares (46,274 units at $216.10), increasing direct ownership by 1% to 3,351,337 units (SEC Form 4)

      4 - RH (0001528849) (Issuer)

      6/27/24 7:47:18 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RH Provides Clarifications Related to the Reciprocal Tariffs Announced on April 2, 2025

      The Company Also Introduces Fiscal 2025 Free Cash Flow Outlook RH (NYSE:RH) provided the following clarifications today based on the market volatility related to the reciprocal tariffs announced on April 2, 2025. The Company has been operating with 25% tariffs from China since the last Trump administration and has successfully resourced the majority of its China production to Vietnam at significantly better than pre-tariff landed China pricing. In addition, the Company has successfully resourced a meaningful amount of its China production to its own factory in North Carolina. As discussed during the Company's fourth quarter earnings call on April 2, 2025, RH believes President Trump is u

      4/4/25 5:58:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH Reports Fourth Quarter and Fiscal 2024 Results

      RH (NYSE:RH) has released its financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.715.9871 or 646.307.1963 for international callers (conference ID: 8284432). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury

      4/2/25 4:05:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH to Report Fourth Quarter and Fiscal Year 2024 Financial Results on April 2, 2025

      RH (NYSE:RH) today announced that it will report financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, on Wednesday, April 2, 2025 after market close. RH's fourth quarter and fiscal year 2024 financial results press release will include a shareholder letter from Chairman and Chief Executive Officer, Gary Friedman, highlighting the Company's continued evolution and recent performance. The shareholder letter and financial results will be posted to the Company's investor relations website at ir.rh.com. RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) on April 2, 2025. The live conference call may be

      3/24/25 6:45:00 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $RH
    SEC Filings

    See more

    $RH
    Leadership Updates

    Live Leadership Updates

    See more

    $RH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • RH downgraded by BofA Securities with a new price target

      BofA Securities downgraded RH from Buy to Underperform and set a new price target of $130.00 from $410.00 previously

      4/3/25 12:54:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH downgraded by Citigroup with a new price target

      Citigroup downgraded RH from Buy to Neutral and set a new price target of $200.00

      4/3/25 8:16:49 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Telsey Advisory Group reiterated coverage on RH with a new price target

      Telsey Advisory Group reiterated coverage of RH with a rating of Outperform and set a new price target of $280.00 from $420.00 previously

      4/3/25 8:00:10 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH filed SEC Form 8-K: Leadership Update

      8-K - RH (0001528849) (Filer)

      4/28/25 4:15:23 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - RH (0001528849) (Filer)

      4/8/25 7:30:10 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form 10-K filed by RH

      10-K - RH (0001528849) (Filer)

      4/2/25 4:59:08 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH Announces the Appointment of Jarrett Stuhl as Chief Real Estate & Development Officer

      RH (NYSE:RH) today announced the appointment of Jarrett Stuhl as Chief Real Estate & Development Officer. Mr. Stuhl will lead Real Estate Development, Architecture & Design for all the Company's brands, concepts and facilities, domestically and internationally. Mr. Stuhl will report to RH's Chairman and Chief Executive Officer, Gary Friedman. Prior to joining RH, Mr. Stuhl spent nine years bringing Soho House & Co. Inc into new markets across the world. Ascending through the company, and lastly serving as Chief Operating Officer for The Americas, Mr. Stuhl had responsibility for real estate, development, membership, communications, food & beverage and hotel operations. Gary Friedman,

      1/18/24 8:32:00 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Remitly Appoints Two New Members to its Board of Directors

      SEATTLE, April 06, 2023 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a leading digital financial services provider for immigrants and their families, today announced the appointments of Phyllis Campbell and Ryno Blignaut to its Board of Directors.  "We are delighted to welcome Phyllis and Ryno to Remitly's Board of Directors," said Matt Oppenheimer, CEO of Remitly. "They each bring with them a wealth of knowledge and leadership experience to complement our existing team of accomplished directors. I'm grateful for their passion and dedication to our customer-centric vision for the future of digital financial services."  Campbell and Blignaut bring decades of leaders

      4/6/23 9:00:00 AM ET
      $RELY
      $RH
      Business Services
      Consumer Discretionary
      Other Specialty Stores
    • Amendment: SEC Form SC 13G/A filed by RH

      SC 13G/A - RH (0001528849) (Subject)

      11/14/24 5:05:51 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by RH

      SC 13G/A - RH (0001528849) (Subject)

      11/14/24 4:15:30 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by RH

      SC 13G/A - RH (0001528849) (Subject)

      11/12/24 10:34:15 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary